These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 35040751)

  • 1. In silico prediction of post-translational modifications in therapeutic antibodies.
    Vatsa S
    MAbs; 2022; 14(1):2023938. PubMed ID: 35040751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidation in the complementarity-determining regions differentially influences the properties of therapeutic antibodies.
    Dashivets T; Stracke J; Dengl S; Knaupp A; Pollmann J; Buchner J; Schlothauer T
    MAbs; 2016; 8(8):1525-1535. PubMed ID: 27612038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting deamidation and isomerization sites in therapeutic antibodies using structure-based
    Hoffmann D; Bauer J; Kossner M; Henry A; Karow-Zwick AR; Licari G
    MAbs; 2024; 16(1):2333436. PubMed ID: 38546837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of methionine oxidation risk in monoclonal antibodies using a machine learning method.
    Sankar K; Hoi KH; Yin Y; Ramachandran P; Andersen N; Hilderbrand A; McDonald P; Spiess C; Zhang Q
    MAbs; 2018; 10(8):1281-1290. PubMed ID: 30252602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein asparagine deamidation prediction based on structures with machine learning methods.
    Jia L; Sun Y
    PLoS One; 2017; 12(7):e0181347. PubMed ID: 28732052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidation and Deamidation of Monoclonal Antibody Products: Potential Impact on Stability, Biological Activity, and Efficacy.
    Gupta S; Jiskoot W; Schöneich C; Rathore AS
    J Pharm Sci; 2022 Apr; 111(4):903-918. PubMed ID: 34890632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current advances in biopharmaceutical informatics: guidelines, impact and challenges in the computational developability assessment of antibody therapeutics.
    Khetan R; Curtis R; Deane CM; Hadsund JT; Kar U; Krawczyk K; Kuroda D; Robinson SA; Sormanni P; Tsumoto K; Warwicker J; Martin ACR
    MAbs; 2022; 14(1):2020082. PubMed ID: 35104168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early engineering approaches to improve peptide developability and manufacturability.
    Furman JL; Chiu M; Hunter MJ
    AAPS J; 2015 Jan; 17(1):111-20. PubMed ID: 25338742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developability Assessment of Engineered Monoclonal Antibody Variants with a Complex Self-Association Behavior Using Complementary Analytical and in Silico Tools.
    Shan L; Mody N; Sormani P; Rosenthal KL; Damschroder MM; Esfandiary R
    Mol Pharm; 2018 Dec; 15(12):5697-5710. PubMed ID: 30395473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualification of a Quantitative Method for Monitoring Aspartate Isomerization of a Monoclonal Antibody by Focused Peptide Mapping.
    Cao M; Mo WD; Shannon A; Wei Z; Washabaugh M; Cash P
    PDA J Pharm Sci Technol; 2016 11/12; 70(6):490-507. PubMed ID: 27091886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel method for in silico assessment of Methionine oxidation risk in monoclonal antibodies: Improvement over the 2-shell model.
    Tavella D; Ouellette DR; Garofalo R; Zhu K; Xu J; Oloo EO; Negron C; Ihnat PM
    PLoS One; 2022; 17(12):e0279689. PubMed ID: 36580468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique Impacts of Methionine Oxidation, Tryptophan Oxidation, and Asparagine Deamidation on Antibody Stability and Aggregation.
    Alam ME; Slaney TR; Wu L; Das TK; Kar S; Barnett GV; Leone A; Tessier PM
    J Pharm Sci; 2020 Jan; 109(1):656-669. PubMed ID: 31678251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico prediction of post-translational modifications.
    Liu C; Li H
    Methods Mol Biol; 2011; 760():325-40. PubMed ID: 21780006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the Potential of Molecular Spectroscopy for the Detection of Post-translational Modifications of a Stressed Biopharmaceutical Protein.
    Corujo MP; Lindo V; Chmel N; Rodger A
    Curr Protein Pept Sci; 2021 Dec; 22(11):800-806. PubMed ID: 34530707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-shot LC-MS/MS analysis of post-translational modifications including oxidation and deamidation of rat lens α- and β-crystallins induced by γ-irradiation.
    Kim I; Saito T; Fujii N; Kanamoto T; Fujii N
    Amino Acids; 2016 Dec; 48(12):2855-2866. PubMed ID: 27600614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of Antibody CDR Residues to Chemical Modifications Can Be Revealed Prior to Antibody Humanization and Aid in the Lead Selection Process.
    Xu A; Kim HS; Estee S; ViaJar S; Galush WJ; Gill A; Hötzel I; Lazar GA; McDonald P; Andersen N; Spiess C
    Mol Pharm; 2018 Oct; 15(10):4529-4537. PubMed ID: 30118239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous monitoring of oxidation, deamidation, isomerization, and glycosylation of monoclonal antibodies by liquid chromatography-mass spectrometry method with ultrafast tryptic digestion.
    Wang Y; Li X; Liu YH; Richardson D; Li H; Shameem M; Yang X
    MAbs; 2016; 8(8):1477-1486. PubMed ID: 27598507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Machine Learning Enables Accurate Prediction of Asparagine Deamidation Probability and Rate.
    Delmar JA; Wang J; Choi SW; Martins JA; Mikhail JP
    Mol Ther Methods Clin Dev; 2019 Dec; 15():264-274. PubMed ID: 31890727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysteinylation of a monoclonal antibody leads to its inactivation.
    McSherry T; McSherry J; Ozaeta P; Longenecker K; Ramsay C; Fishpaugh J; Allen S
    MAbs; 2016; 8(4):718-25. PubMed ID: 27050640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in silico assessment of the developability of a designed monoclonal antibody library.
    Wolf Pérez AM; Sormanni P; Andersen JS; Sakhnini LI; Rodriguez-Leon I; Bjelke JR; Gajhede AJ; De Maria L; Otzen DE; Vendruscolo M; Lorenzen N
    MAbs; 2019; 11(2):388-400. PubMed ID: 30523762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.